Year |
Citation |
Score |
2020 |
Monickaraj F, Oruganti SR, McGuire P, Das A. A potential novel therapeutic target in diabetic retinopathy: a chemokine receptor (CCR2/CCR5) inhibitor reduces retinal vascular leakage in an animal model. Graefe's Archive For Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie. PMID 32816099 DOI: 10.1007/S00417-020-04884-5 |
0.517 |
|
2020 |
Rangasamy S, Monickaraj F, Legendre C, Cabrera AP, Llaci L, Bilagody C, McGuire P, Das A. Transcriptomics analysis of pericytes from retinas of diabetic animals reveals novel genes and molecular pathways relevant to blood-retinal barrier alterations in diabetic retinopathy. Experimental Eye Research. 195: 108043. PMID 32376470 DOI: 10.1016/J.Exer.2020.108043 |
0.412 |
|
2020 |
Cabrera AP, Monickaraj F, Rangasamy S, Hobbs S, McGuire P, Das A. Do Genomic Factors Play a Role in Diabetic Retinopathy? Journal of Clinical Medicine. 9. PMID 31947513 DOI: 10.3390/Jcm9010216 |
0.375 |
|
2017 |
Monickaraj F, McGuire P, Das A. Cathepsin D plays a role in endothelial-pericyte interactions during alteration of the blood-retinal barrier in diabetic retinopathy. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. PMID 29263022 DOI: 10.1096/Fj.201700781Rr |
0.435 |
|
2017 |
Urias EA, Urias GA, Monickaraj F, McGuire P, Das A. Novel Therapeutic Targets in Diabetic Macular Edema: Beyond VEGF. Vision Research. PMID 28993218 DOI: 10.1016/J.Visres.2017.06.015 |
0.504 |
|
2017 |
Hobbs S, Monickaraj F, McGuire P, Das A. Role of Inflammation in Diabetic Retinopathy:Therapeutic Targets Current Science. 113: 1287. DOI: 10.18520/Cs/V113/I07/1287-1295 |
0.326 |
|
2016 |
Das A, McGuire PG, Monickaraj F. Novel pharmacotherapies in diabetic retinopathy: Current status and what's in the horizon? Indian Journal of Ophthalmology. 64: 4-13. PMID 26953018 DOI: 10.4103/0301-4738.178154 |
0.419 |
|
2015 |
Monickaraj F, McGuire PG, Nitta CF, Ghosh K, Das A. Cathepsin D: an Mϕ-derived factor mediating increased endothelial cell permeability with implications for alteration of the blood-retinal barrier in diabetic retinopathy. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. PMID 26718887 DOI: 10.1096/Fj.15-279802 |
0.36 |
|
2015 |
Yang X, Scott HA, Monickaraj F, Xu J, Ardekani S, Nitta CF, Cabrera A, McGuire PG, Mohideen U, Das A, Ghosh K. Basement membrane stiffening promotes retinal endothelial activation associated with diabetes. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. PMID 26443820 DOI: 10.1096/Fj.15-277962 |
0.449 |
|
2015 |
Das A, McGuire PG, Rangasamy S. Diabetic Macular Edema: Pathophysiology and Novel Therapeutic Targets. Ophthalmology. 122: 1375-94. PMID 25935789 DOI: 10.1016/j.ophtha.2015.03.024 |
0.407 |
|
2015 |
Zetterqvist AV, Blanco F, Öhman J, Kotova O, Berglund LM, de Frutos Garcia S, Al-Naemi R, Wigren M, McGuire PG, Gonzalez Bosc LV, Gomez MF. Nuclear factor of activated T cells is activated in the endothelium of retinal microvessels in diabetic mice. Journal of Diabetes Research. 2015: 428473. PMID 25918731 DOI: 10.1155/2015/428473 |
0.42 |
|
2014 |
Rangasamy S, McGuire PG, Franco Nitta C, Monickaraj F, Oruganti SR, Das A. Chemokine mediated monocyte trafficking into the retina: role of inflammation in alteration of the blood-retinal barrier in diabetic retinopathy. Plos One. 9: e108508. PMID 25329075 DOI: 10.1371/journal.pone.0108508 |
0.387 |
|
2012 |
Rangasamy S, McGuire PG, Das A. Diabetic retinopathy and inflammation: novel therapeutic targets. Middle East African Journal of Ophthalmology. 19: 52-9. PMID 22346115 DOI: 10.4103/0974-9233.92116 |
0.427 |
|
2011 |
McGuire PG, Rangasamy S, Maestas J, Das A. Pericyte-derived sphingosine 1-phosphate induces the expression of adhesion proteins and modulates the retinal endothelial cell barrier. Arteriosclerosis, Thrombosis, and Vascular Biology. 31: e107-15. PMID 21940944 DOI: 10.1161/ATVBAHA.111.235408 |
0.336 |
|
2011 |
Pisanti S, Picardi P, Prota L, Proto MC, Laezza C, McGuire PG, Morbidelli L, Gazzerro P, Ziche M, Das A, Bifulco M. Genetic and pharmacologic inactivation of cannabinoid CB1 receptor inhibits angiogenesis. Blood. 117: 5541-50. PMID 21460248 DOI: 10.1182/blood-2010-09-307355 |
0.35 |
|
2011 |
Rangasamy S, Srinivasan R, Maestas J, McGuire PG, Das A. A potential role for angiopoietin 2 in the regulation of the blood-retinal barrier in diabetic retinopathy. Investigative Ophthalmology & Visual Science. 52: 3784-91. PMID 21310918 DOI: 10.1167/iovs.10-6386 |
0.396 |
|
2009 |
Basu A, Menicucci G, Maestas J, Das A, McGuire P. Plasminogen activator inhibitor-1 (PAI-1) facilitates retinal angiogenesis in a model of oxygen-induced retinopathy. Investigative Ophthalmology & Visual Science. 50: 4974-81. PMID 19443721 DOI: 10.1167/Iovs.09-3619 |
0.526 |
|
2008 |
Navaratna D, Maestas J, McGuire PG, Das A. Suppression of retinal neovascularization with an antagonist to vascular endothelial cadherin. Archives of Ophthalmology (Chicago, Ill. : 1960). 126: 1082-8. PMID 18695103 DOI: 10.1001/archopht.126.8.1082 |
0.432 |
|
2008 |
Navaratna D, Menicucci G, Maestas J, Srinivasan R, McGuire P, Das A. A peptide inhibitor of the urokinase/urokinase receptor system inhibits alteration of the blood-retinal barrier in diabetes. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 22: 3310-7. PMID 18559877 DOI: 10.1096/Fj.08-110155 |
0.519 |
|
2007 |
Navaratna D, McGuire PG, Menicucci G, Das A. Proteolytic degradation of VE-cadherin alters the blood-retinal barrier in diabetes. Diabetes. 56: 2380-7. PMID 17536065 DOI: 10.2337/db06-1694 |
0.426 |
|
2007 |
Colombo ES, Menicucci G, McGuire PG, Das A. Hepatocyte growth factor/scatter factor promotes retinal angiogenesis through increased urokinase expression. Investigative Ophthalmology & Visual Science. 48: 1793-800. PMID 17389513 DOI: 10.1167/Iovs.06-0923 |
0.358 |
|
2006 |
Das A, McGuire P. Role of urokinase inhibitors in choroidal neovascularization. Seminars in Ophthalmology. 21: 23-7. PMID 16517441 DOI: 10.1080/08820530500509366 |
0.474 |
|
2006 |
Majka S, Fox K, McGuire B, Crossno J, McGuire P, Izzo A. Pleiotropic role of VEGF-A in regulating fetal pulmonary mesenchymal cell turnover American Journal of Physiology-Lung Cellular and Molecular Physiology. 290. PMID 16428272 DOI: 10.1152/Ajplung.00175.2005 |
0.385 |
|
2005 |
Giebel SJ, Menicucci G, McGuire PG, Das A. Matrix metalloproteinases in early diabetic retinopathy and their role in alteration of the blood-retinal barrier. Laboratory Investigation; a Journal of Technical Methods and Pathology. 85: 597-607. PMID 15711567 DOI: 10.1038/labinvest.3700251 |
0.306 |
|
2003 |
Das A, Fanslow W, Cerretti D, Warren E, Talarico N, McGuire P. Angiopoietin/Tek interactions regulate mmp-9 expression and retinal neovascularization. Laboratory Investigation; a Journal of Technical Methods and Pathology. 83: 1637-45. PMID 14615417 DOI: 10.1097/01.Lab.0000097189.79233.D8 |
0.514 |
|
2003 |
Das A, McGuire PG. Retinal and choroidal angiogenesis: pathophysiology and strategies for inhibition. Progress in Retinal and Eye Research. 22: 721-48. PMID 14575722 |
0.531 |
|
2003 |
McGuire PG, Jones TR, Talarico N, Warren E, Das A. The urokinase/urokinase receptor system in retinal neovascularization: inhibition by A6 suggests a new therapeutic target. Investigative Ophthalmology & Visual Science. 44: 2736-42. PMID 12766081 |
0.426 |
|
2002 |
Majka S, McGuire PG, Das A. Regulation of matrix metalloproteinase expression by tumor necrosis factor in a murine model of retinal neovascularization. Investigative Ophthalmology & Visual Science. 43: 260-6. PMID 11773040 |
0.447 |
|
2001 |
Green WB, McGuire PG, Miska KB, Kusewitt DF. Urokinase activity in corneal fibroblasts may be modulated by DNA damage and secreted proteins. Photochemistry and Photobiology. 73: 318-23. PMID 11281030 DOI: 10.1562/0031-8655(2001)073<0318:UAICFM>2.0.CO;2 |
0.334 |
|
1999 |
Das A, McLamore A, Song W, McGuire PG. Retinal neovascularization is suppressed with a matrix metalloproteinase inhibitor. Archives of Ophthalmology (Chicago, Ill. : 1960). 117: 498-503. PMID 10206578 DOI: 10.1001/ARCHOPHT.117.4.498 |
0.431 |
|
1999 |
Song W, Majka SM, McGuire PG. Hepatocyte growth factor expression in the developing myocardium: evidence for a role in the regulation of the mesenchymal cell phenotype and urokinase expression. Developmental Dynamics : An Official Publication of the American Association of Anatomists. 214: 92-100. PMID 9915579 DOI: 10.1002/(SICI)1097-0177(199901)214:1<92::AID-DVDY9>3.0.CO;2-X |
0.341 |
|
Show low-probability matches. |